Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already ...

Find out more about five biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

As part of our series In Good Health, we discuss these new medications and the falling rate of obesity.

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.

A new study shows semaglutide medications, such as Ozempic and Wegovy, may be effective in treating hidradenitis suppurativa ...